BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 6, 2009
View Archived Issues
Proteon Snares $38M Round, and $550M Novartis Option
Proteon Therapeutics Inc. is banking on its lead product to clear a crucial Phase II study, the results of which could seal a $550 million deal with Novartis AG. (BioWorld Today)
Read More
Optimer's Anti-Infective Pipeline Moving Ahead Via $33M Offering
Read More
Ortho Group Says Biologics Are no Longer 'Back in the Corner'
Read More
Obama Ties Health Reform To Prosperity of the U.S.
Read More
Isolagen Shares Jump 30% on Good Acne Trial Data
Read More
Other News To Note
Read More
Clinic Roundup
Read More